A procedure for the rapid purification in high yield of human glucocerebrosidase using immunoaffinity chromatography with monoclonal antibodies.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Analytical Biochemistry

• Publication date

  1986-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0003-2697(86)90043-6PMID 3728974
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Purification of beta-glucocerebrosidase by preparative-scale high-performance liquid chromatography: the use of ethylene glycol-containing buffers for chromatography of hydrophobic glycoprotein enzymes.

  1985cited by this paper
• Biosynthesis of the lysosomal enzyme glucocerebrosidase.

  1985cited by this paper
• The occurrence of two immunologically distinguishable beta-glucocerebrosidases in human spleen.

  1985cited by this paper
• Human lysosomal β-glucosidase: Purification by affinity chromatography

  1984cited by this paper
• Human lysosomal beta-glucosidase: purification by affinity chromatography.

  1984cited by this paper
• Molecular weight characterization of beta-D-glucocerebrosidase in mononuclear white blood cells in Gaucher's disease.

  1984cited by this paper
• Monoclonal antibodies against human beta-glucocerebrosidase.

  1983cited by this paper
• Determination of Gaucher's disease phenotypes with monoclonal antibody.

  1983cited by this paper
• Purification of glucosylceramidase by affinity chromatography.

  1982cited by this paper
• Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease.

  1982cited by this paper
• [Properties of the molecular forms of beta-glucosidase and beta-glucocerebrosidase from normal human and Gaucher disease spleen (author's transl)].

  1981cited by this paper
• A new group of glucocerebrosidase isozymes found in human white blood cells.

  1980cited by this paper
• Gaucher disease: isolation and comparison of normal and mutant glucocerebrosidase from human spleen tissue.

  1978cited by this paper
• Enzyme replacement therapy in Gaucher's disease: large-scale purification of glucocerebrosidase suitable for human administration.

  1977cited by this paper
• Enzyme replacement therapy in Gaucher's disease: a rapid, high-yield method for purification of glucocerebrosidase.

  1976cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Thin-layer isoelectric focusing of proteins.

  1969cited by this paper
• METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.

  1965cited by this paper
• A Deficiency of Glucocerebrosidase in Gaucher's Disease

  1965cited by this paper

• Cultured Macrophage Models for the Investigation of Lysosomal Glucocerebrosidase and Gaucher Disease

  2025cites this paper
• Selective labelling of GBA2 in cells with fluorescent β-d-arabinofuranosyl cyclitol aziridines

  2024cites this paper
• The human disease gene LYSET is essential for lysosomal enzyme transport and viral infection

  2022cites this paper
• Recombinant β-Glucocerebrosidase specific immunoaffinity ligands selected from phage-displayed combinatorial scFv libraries.

  2020cites this paper
• Novel defect in phosphatidylinositol 4‐kinase type 2‐alpha (PI4K2A) at the membrane‐enzyme interface is associated with metabolic cutis laxa

  2020cites this paper
• Validation of anti-glucocerebrosidase antibodies for western blot analysis on protein lysates of murine and human cells.

  2019cites this paper
• Investigations on therapeutic glucocerebrosidases through paired detection with fluorescent activity-based probes

  2017cites this paper
• Stereodivergent synthesis of right- and left-handed iminoxylitol heterodimers and monomers. Study of their impact on β-glucocerebrosidase activity.

  2017cites this paper
• In situ visualization of glucocerebrosidase in human skin tissue: zymography versus activity-based probe labeling[S]

  2017cites this paper
• UvA-DARE ( Digital Academic Repository ) Glycosphingolipids and the central regulation of metabolism Sugar analogues as research tools

  2017cites this paper
• University of Groningen Stabilization of Glucocerebrosidase by Active Site Occupancy

  2017cites this paper
• Investigation of original multivalent iminosugars as pharmacological chaperones for the treatment of Gaucher disease.

  2016cites this paper
• ERdj3 is an endoplasmic reticulum degradation factor for mutant glucocerebrosidase variants linked to Gaucher's disease.

  2014cites this paper
• Glucocerebrosidase Enhancers for Selected Gaucher Disease Genotypes by Modification of α‐1‐C‐Substituted Imino‐D‐xylitols (DIXs) by Click Chemistry

  2014cites this paper
• Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis

  2014cites this paper
• Activity-based probes for retaining β-glucosidases: Novel tools for research and diagnostics

  2014cites this paper
• Selective chaperone effect of aminocyclitol derivatives on G202R and other mutant glucocerebrosidases causing Gaucher disease.

  2014cites this paper
• Alglucerase

  2012cites this paper
• Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies

  2011cites this paper
• Hypersensitive response to over-reactive cysteines.

  2011cites this paper
• Affinity chromatography.

  2011cites this paper
• Ultrasensitive in situ visualization of active glucocerebrosidase molecules.

  2010cites this paper
• Detection of mutant protein in complex biological samples: glucocerebrosidase mutations in Gaucher's disease.

  2008cites this paper
• Chapter Ten Chapter Ten Detection of mutant protein in complex biological samples: glucocerebrosidase mutations in Gaucher disease

  2008cites this paper
• Synthesis and characterization of a bioactive 82-residue sphingolipid activator protein, saposin C

  2007cites this paper
• Chemical chaperones and permissive temperatures alter localization of Gaucher disease associated glucocerebrosidase variants.

  2006cites this paper
• Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease.

  2005cites this paper
• The N370S (Asn370-->Ser) mutation affects the capacity of glucosylceramidase to interact with anionic phospholipid-containing membranes and saposin C.

  2005cites this paper
• Recombinant human acid β-glucosidase stored in tobacco seed is stable, active and taken up by human fibroblasts

  2004influential citation
• Macrofages as therapeutic targets in lysosomal storage disorders

  2003cites this paper
• Biochemistry of glycosphingolipid storage disorders: implications for therapeutic intervention.

  2003cites this paper
• Cytosolic pyridoxine-beta-D-glucoside hydrolase from porcine jejunal mucosa. Purification, properties, and comparison with broad specificity beta-glucosidase.

  1997cites this paper
• Cytosolic Pyridoxine-β-d-Glucoside Hydrolase from Porcine Jejunal Mucosa

  1997cites this paper
• The enzymatic hydrolysis of 6-acylamino-4-methylumbelliferyl-beta-D-glucosides: identification of a novel human acid beta-glucosidase.

  1996cites this paper
• Enzymatic and molecular diagnosis of Gaucher disease.

  1995cites this paper
• Molecular biology of glucocerebrosidase and the treatment of Gaucher disease.

  1995cites this paper
• Position of the sulfhydryl group and the disulfide bonds of human glucocerebrosidase

  1995cites this paper
• Identification of the binding and activating sites of the sphingolipid activator protein, saposin C, with glucocerebrosidase

  1995cites this paper
• Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease.

  1993cites this paper
• Production and Application of Polyclonal and Monoclonal Antibodies

  1993cites this paper
• Isolation and characterization of a polyol-responsive monoclonal antibody useful for gentle purification of Escherichia coli RNA polymerase.

  1992cites this paper
• Federal and private roles in the development and provision of alglucerase therapy for Gaucher disease

  1992cites this paper
• Creating the Costliest Orphan: The Orphan Drug Act in the Development of Ceredase™

  1992cites this paper
• Expression of human glucocerebrosidase following retroviral vector-mediated transduction of murine hematopoietic stem cells.

  1991cites this paper
• Mannose 6-phosphate-independent membrane association of cathepsin D, glucocerebrosidase, and sphingolipid-activating protein in HepG2 cells.

  1991cites this paper
• Characterization of human glucocerebrosidase from different mutant alleles.

  1991cites this paper
• Acid beta-glucosidase: enzymology and molecular biology of Gaucher disease.

  1990cites this paper
• Purification of pyruvate kinase from human erythrocytes by immunoaffinity chromatography.

  1990cites this paper
• Function of oligosaccharide modification in glucocerebrosidase, a membrane-associated lysosomal hydrolase.

  1990cites this paper
• Purification of eukaryotic RNA polymerase II by immunoaffinity chromatography. Elution of active enzyme with protein stabilizing agents from a polyol-responsive monoclonal antibody.

  1990cites this paper
• Acid β-Glucosidase: Enzymology and Molecular Biology of Gaucher Diseas

  1990cites this paper
• Biochemistry and Molecular Biology Acid p-Glucosidase: Enzymology And Molecular Biology of Gaucher Disease

  1990cites this paper
• Purification and Immunological Reactivity of Commercial Microbial Milk Clotting Enzyme Preparations

  1990influential citation
• Conditions affecting the activity of glucocerebrosidase purified from spleens of control subjects and patients with type 1 Gaucher disease.

  1990cites this paper
• Sequence of Two Alleles Responsible for Gaucher Disease

  1990influential citation
• Interaction of saposins, acidic lipids, and glucosylceramidase.

  1990cites this paper
• Comparative study on glucocerebrosidase in spleens from patients with Gaucher disease.

  1990cites this paper
• Expression of human glucocerebrosidase in murine long-term bone marrow cultures after retroviral vector-mediated transfer.

  1990cites this paper
• Activity of glucocerebrosidase in extracts of different cell types from type 1 Gaucher disease patients

  1990cites this paper
• Purification of lysosomal membrane-bound glucocerebrosidase from human cultured fibroblasts using high-performance liquid chromatography.

  1989cites this paper
• Gaucher's disease: advances and challenges.

  1989cites this paper
• Kinetic analysis of the interaction of alkyl glycosides with two human beta-glucosidases.

  1989cites this paper
• Mammalian glucocerebrosidase: implications for Gaucher's disease.

  1988cites this paper
• Glucocerebrosidase, a lysosomal enzyme that does not undergo oligosaccharide phosphorylation.

  1988cites this paper
• Molecular Properties of Lysosomal Glucocerebrosidase

  1988cites this paper
• The time-dependent distribution of 125I-asialo-orosomucoid-horseradish peroxidase and 131I-immunoglobulin A among three endosomal subfractions isolated from rat liver.

  1988cites this paper
• Characterization of glucocerebrosidase in peripheral blood cells and cultured blastoid cells.

  1988cites this paper
• Glucocerebrosidase, a Membrane-Associated Lysosomal Enzyme Deficient in Gaucher Disease

  1987cites this paper
• Relationship between the two immunologically distinguishable forms of glucocerebrosidase in tissue extracts.

  1987cites this paper
• Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts.

  1987cites this paper
• Comparison of the properties of a soluble form of glucocerebrosidase from human urine with those of the membrane-associated tissue enzyme.

  1986cites this paper